Cargando…
Characterization of TGFβ-associated molecular features and drug responses in gastrointestinal adenocarcinoma
BACKGROUND: Gastrointestinal adenocarcinoma (GIAD) has caused a serious disease burden globally. Targeted therapy for the transforming growth factor beta (TGF-β) signaling pathway is becoming a reality. However, the molecular characterization of TGF-β associated signatures in GIAD requires further e...
Autores principales: | Zhang, Qiaofeng, Liu, Furong, Qin, Lu, Liao, Zhibin, Song, Jia, Liang, Huifang, Chen, Xiaoping, Zhang, Zhanguo, Zhang, Bixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274021/ https://www.ncbi.nlm.nih.gov/pubmed/34247571 http://dx.doi.org/10.1186/s12876-021-01869-4 |
Ejemplares similares
-
Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma
por: Han, Mengzhen, et al.
Publicado: (2020) -
The role of RNA m(5)C modification in cancer metastasis
por: Zhang, Qiaofeng, et al.
Publicado: (2021) -
A micropeptide JunBP regulated by TGF-β promotes hepatocellular carcinoma metastasis
por: Zhang, Hongwei, et al.
Publicado: (2022) -
Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020) -
Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression
por: Liu, Furong, et al.
Publicado: (2023)